课题基金 / 基金详情

Sudies on the differention and activation mechanisms of T cell via lymphocye functioning antigen (LFA).

Sudies on the differention and activation mechanisms of T cell via lymphocye functioning antigen (LFA).
通过淋巴细胞功能抗原(LFA)研究T细胞的分化和激活机制。
批准号:
04404035
负责人:
OKUMURA Ko
金额:
$10.88万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for General Scientific Research (A)
财政年份:
1992
资助国家:
日本
项目状态:
已结题
起止时间:
1992 至 1994

项目摘要

项目成果

OKUMURA Ko的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
We performed the study to know how lymphocyte function associated antigens (LEA) on T cell are involved in various kind of immune responses. To analyzes it's mechanisms, we at first reported the effect of in vivo administration on the induction of tolerance by using mouse heart allograft experimental system. Then, it was revealed that absence of costimulatory signals from LFA-1 could induce T cell anergy. To investigate more detailed mechanisms of T cell tolerance, we further analyzed the role of other LFA in terms of T cell anergy induction. Then, we further analyzed the role of other LEA on T cell as well as those ligand molecules on antigen presenting all (APC). On the way of study, we could identify CD48 as unknown ligand of mouse CD2. By using monoclonal antibody to those molecules which we established, we could examine the biological significance of CD2 and CD48/LFA-3 pathway. Regarding to the signals from CD28 of T cell, we succeeded to identify unknown ligand on APC and name B70 (CD86). By using cDNA of B70 as well as monoclonal antibody, we could expand the study how CD28 and CD80/CD86 pathway is important to understand the intiation of T cell immune reponse as well as anergy induction and/or maintenance of T cell torelance. Especially using in vivo experimental systems, the administration of antiCD80 and antiCD86 could induce permanent torelance in the donor received allograft.
期刊论文(33)
专著(0)
科研奖励(0)
会议论文
Yagita, H.: "Proceedings of the first green cross international symposium "Immunology for tomorrow" 1992- molecular basis of Immune responses." Academic Press, Inc.59-69 (1993)
Yagita, H.:“1992 年第一届绿十字国际研讨会“明天的免疫学”会议记录——免疫反应的分子基础。”
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Kato,K.: "idenification of a T cell surface signal-turansducing glycoprotein, sgp-60, as CD48 that is a counter-receptor for mouse CD2." Eur.J.Immunol.(1993)
Kato,K.:“T 细胞表面信号转导糖蛋白 sgp-60 的鉴定,即 CD48,它是小鼠 CD2 的反受体。”
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Caux,C.: "B70/B7-2 is identical to CD86 and is the major functional ligand for CD28 expressed on human dendritic cells." J.Exp.Med.180. 1841-1847 (1994)
Caux,C.:“B70/B7-2 与 CD86 相同,是人类树突细胞上表达的 CD28 的主要功能配体。”
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Hanabuchi S.: "Fas and its ligand in a general mechanism of T cell-mediated cytotoxity." Proc.Natl.Acad.Sci.USA. 91. 4930-4934 (1994)
Hanabuchi S.:“T 细胞介导的细胞毒性的一般机制中的 Fas 及其配体。”
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
25
    Development of the antibody medical treatment to autoimmune and asthmatic diseases based on new target molecule.
    • 批准号:
      23390260
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $12.31万
    • 财政年份:
      2011
    • 负责人:
      OKUMURA Ko
    • 依托单位:
    Studies on wetting and fracture based on the spirit of impressionistic physics
    • 批准号:
      20340110
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $6.74万
    • 财政年份:
      2008
    • 负责人:
      OKUMURA Ko
    • 依托单位:
    Development of strategy to treat allergic diseases via targeting surface molecules on lymphocytes and intracellular signaling molecules
    • 批准号:
      20390282
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $11.9万
    • 财政年份:
      2008
    • 负责人:
      OKUMURA Ko
    • 依托单位:
    Statistical analyses of allergy-related polymorphisms
    • 批准号:
      07F07462
    • 项目类别:
      Grant-in-Aid for JSPS Fellows
    • 资助金额:
      $1.47万
    • 财政年份:
      2007
    • 负责人:
      OKUMURA Ko
    • 依托单位:
    国内基金
    海外基金
    MSI2 通过 YTHDF2 介导的m6A 修饰调控CD48/CD244 信号通路促进急性髓系白血病免疫逃逸的机制研究
    • 批准号:
      ZCLQN26H0801
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2026
    • 负责人:
      李帆帆
    • 依托单位:
    GDF15通过CD48介导肿瘤相关巨噬细胞亚型转变促进肝癌免疫逃逸的分子机制研究